 PHILADELPHIA and OXFORDSHIRE, United Kingdom, March 08, 2022 GLOBE NEWSWIRE -- Adaptimmune Therapeutics plc Nasdaq:ADAP, a leader in cell therapy to treat cancer, will report financial results and provide business updates for the fourth quarter and year ended December 31, 2021, before the US markets open on Monday, March 14, 2022. Following the announcement, the Company will host a live teleconference and webcast at 8:30 a.m. EDT 12:30 p.m. GMT that same day details below. 